한글목차

인공 혈관 세계 시장은 2024년 3억 158만 달러로 평가되었으며 예측 기간 동안 CAGR 5.74%로 성장할 전망이며, 2030년에는 4억 2,151만 달러에 이를 것으로 예측됩니다.

이 시장은 의료기기 산업의 중요한 부문이며, 심혈관 및 혈관 질환의 치료용 인공 혈관의 개발과 응용에 초점을 맞추었습니다. 이 분야에서는 재료 과학과 이식편의 설계에 현저한 진보가 보이고, 안전성, 내구성, 수술 성적이 향상되고 있습니다.

시장 성장 촉진요인

심혈관 질환의 유병률 상승

주요 시장 과제

규제상의 장애물 및 승인 프로세스

주요 시장 동향

생분해성 재료 및 바이오엔지니어링 재료

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 인공 혈관 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 용도별(대동맥질환, 말초동맥질환, 혈액투석)
  • 폴리머별(폴리디옥사논, 엘라스토머, 폴리에틸렌테레프탈레이트, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 인공 혈관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 인공 혈관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 인공 혈관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 인공 혈관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 인공 혈관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제13장 세계의 인공 혈관 시장 : SWOT 분석

제14장 경쟁 구도

• B. Braun Melsungen
• Becton, Dickinson and Company
• Cook Medical Incorporated
• Humacyte Inc.
• Jotec GmbH
• LeMaitre Vascular Inc
• Medtronic Inc
• Techshot Inc
• Terumo Medical Corporation
• WL Gore & Associates, Inc.

제15장 전략적 제안

제16장 기업 소개와 면책사항

영문목차

The Global Artificial Blood Vessels Market was valued at USD 301.58 million in 2024 and is projected to reach USD 421.51 million by 2030, expanding at a CAGR of 5.74% during the forecast period. This market represents a vital segment of the medical device industry, focusing on the development and application of vascular grafts for treating cardiovascular and vascular conditions. Artificial blood vessels, both synthetic and tissue-engineered, are integral to life-saving procedures such as bypass surgeries, hemodialysis access, and aortic repair, especially when natural vessels are unsuitable or unavailable. The sector has seen notable advancements in material science and graft design, enhancing safety, durability, and surgical outcomes. Additionally, the shift towards minimally invasive procedures has accelerated demand for advanced vascular grafts that reduce recovery times and procedural risks, positioning the market for sustained growth.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The escalating incidence of cardiovascular diseases-such as coronary artery and peripheral arterial diseases-serves as a major catalyst for the artificial blood vessels market. This rise is driven by sedentary lifestyles, increased consumption of processed foods, and a surge in obesity and diabetes, all contributing to vascular complications. The global trend of aging populations further exacerbates vulnerability to arterial disorders due to natural physiological changes. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths annually, highlighting the urgent need for advanced vascular solutions. A hereditary predisposition to heart disease and the health impacts of urbanization, including pollution and stress, also heighten the need for effective interventions like artificial grafts, thereby stimulating market growth.

Key Market Challenges

Regulatory Hurdles and Approval Processes

One of the major challenges facing the artificial blood vessels market is navigating the stringent regulatory frameworks required for medical device approval. Compliance with rigorous standards from authorities such as the FDA and EMA involves lengthy and costly clinical evaluations, often delaying product launches. These regulatory procedures can vary significantly across regions, complicating global distribution strategies. Additionally, the focus on patient safety means that any adverse events or safety concerns can trigger intensified scrutiny, potential recalls, and prolonged approval timelines, thereby impeding market entry and expansion.

Key Market Trends

Biodegradable and Bioengineered Materials

A significant trend in the artificial blood vessels market is the adoption of biodegradable and bioengineered materials that emulate the characteristics of natural vessels. These innovations enhance biocompatibility and minimize risks of clotting or immune reactions. Designed to gradually dissolve and integrate with patient tissue, these materials can help reduce long-term complications such as graft failure or calcification. Moreover, their customizable nature allows for tailored solutions that align with individual patient anatomies, improving fit and performance while reducing the risk of rejection, thus paving the way for personalized vascular care.

Key Market Players

• B. Braun Melsungen
• Becton, Dickinson and Company
• Cook Medical Incorporated
• Humacyte Inc.
• Jotec GmbH
• LeMaitre Vascular Inc
• Medtronic Inc
• Techshot Inc
• Terumo Medical Corporation
• W. L. Gore & Associates, Inc.

Report Scope:

In this report, the Global Artificial Blood Vessels Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Blood Vessels Market, By Application:

• Aortic Disease
• Peripheral Artery Disease
• Haemodialysis

Artificial Blood Vessels Market, By Polymer:

• Polydioxanone
• Elastomer
• Polyethylene Terephthalate
• Others

Artificial Blood Vessels Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Blood Vessels Market.

Available Customizations:

Global Artificial Blood Vessels market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Blood Vessels Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Aortic Disease, Peripheral Artery Disease, Haemodialysis)
  • 5.2.2. By Polymer (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Artificial Blood Vessels Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Polymer
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Artificial Blood Vessels Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Polymer
  • 6.3.2. Canada Artificial Blood Vessels Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Polymer
  • 6.3.3. Mexico Artificial Blood Vessels Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Polymer

7. Europe Artificial Blood Vessels Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Polymer
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Artificial Blood Vessels Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Polymer
  • 7.3.2. United Kingdom Artificial Blood Vessels Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Polymer
  • 7.3.3. Italy Artificial Blood Vessels Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Polymer
  • 7.3.4. France Artificial Blood Vessels Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Polymer
  • 7.3.5. Spain Artificial Blood Vessels Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Polymer

8. Asia-Pacific Artificial Blood Vessels Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Polymer
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Artificial Blood Vessels Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Polymer
  • 8.3.2. India Artificial Blood Vessels Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Polymer
  • 8.3.3. Japan Artificial Blood Vessels Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Polymer
  • 8.3.4. South Korea Artificial Blood Vessels Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Polymer
  • 8.3.5. Australia Artificial Blood Vessels Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Polymer

9. South America Artificial Blood Vessels Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Polymer
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Artificial Blood Vessels Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Polymer
  • 9.3.2. Argentina Artificial Blood Vessels Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Polymer
  • 9.3.3. Colombia Artificial Blood Vessels Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Polymer

10. Middle East and Africa Artificial Blood Vessels Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Polymer
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Artificial Blood Vessels Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Polymer
  • 10.3.2. Saudi Arabia Artificial Blood Vessels Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Polymer
  • 10.3.3. UAE Artificial Blood Vessels Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Polymer

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Artificial Blood Vessels Market: SWOT Analysis

14. Competitive Landscape

• 14.1. B. Braun Melsungen
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Becton, Dickinson and Company
• 14.3. Cook Medical Incorporated
• 14.4. Humacyte Inc.
• 14.5. Jotec GmbH
• 14.6. LeMaitre Vascular Inc
• 14.7. Medtronic Inc
• 14.8. Techshot Inc
• 14.9. Terumo Medical Corporation
• 14.10. W. L. Gore & Associates, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer